Wedbush Lowers Healthpeak Properties (NYSE:DOC) Price Target to $22.00

Healthpeak Properties (NYSE:DOC - Get Free Report) had its price target lowered by equities researchers at Wedbush from $24.00 to $22.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has an "outperform" rating on the real estate investment trust's stock. Wedbush's price target suggests a potential upside of 23.18% from the company's previous close. Wedbush also issued estimates for Healthpeak Properties' FY2026 earnings at $1.95 EPS.

Other analysts have also issued research reports about the stock. Scotiabank dropped their target price on shares of Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating on the stock in a research report on Friday, February 28th. Robert W. Baird cut their price objective on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a research note on Tuesday, February 11th. Morgan Stanley upgraded Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 target price on the stock in a research report on Wednesday, January 15th. Finally, StockNews.com cut Healthpeak Properties from a "hold" rating to a "sell" rating in a research report on Wednesday, April 23rd. One analyst has rated the stock with a sell rating, three have issued a hold rating and nine have given a buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $23.42.

Healthpeak Properties Stock Performance

NYSE DOC traded up $0.10 on Monday, reaching $17.86. 7,752,807 shares of the company's stock traded hands, compared to its average volume of 4,920,357. The firm has a market cap of $12.49 billion, a price-to-earnings ratio of 51.03, a P/E/G ratio of 2.17 and a beta of 1.02. The stock has a 50 day moving average price of $19.49 and a 200-day moving average price of $20.51. Healthpeak Properties has a fifty-two week low of $17.33 and a fifty-two week high of $23.26. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.35 and a current ratio of 1.35.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting the consensus estimate of $0.46. The firm had revenue of $702.89 million during the quarter, compared to analyst estimates of $690.76 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 9.00%. Healthpeak Properties's revenue for the quarter was up 15.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.45 EPS. Equities research analysts predict that Healthpeak Properties will post 1.86 EPS for the current fiscal year.

Insider Activity

In other Healthpeak Properties news, CEO Scott M. Brinker bought 11,337 shares of the business's stock in a transaction on Monday, April 28th. The stock was bought at an average price of $17.68 per share, with a total value of $200,438.16. Following the completion of the purchase, the chief executive officer now directly owns 201,863 shares in the company, valued at $3,568,937.84. The trade was a 5.95 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director John T. Thomas purchased 4,200 shares of the firm's stock in a transaction dated Monday, April 28th. The stock was acquired at an average cost of $17.84 per share, for a total transaction of $74,928.00. Following the purchase, the director now owns 813,566 shares in the company, valued at approximately $14,514,017.44. The trade was a 0.52 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 0.23% of the company's stock.

Institutional Investors Weigh In On Healthpeak Properties

A number of institutional investors have recently made changes to their positions in the stock. Principal Financial Group Inc. boosted its position in shares of Healthpeak Properties by 2,113.5% during the 4th quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust's stock worth $367,575,000 after purchasing an additional 17,314,572 shares during the period. Norges Bank acquired a new position in Healthpeak Properties during the fourth quarter worth $166,804,000. Resolution Capital Ltd purchased a new position in shares of Healthpeak Properties during the fourth quarter worth $122,795,000. Long Pond Capital LP acquired a new stake in shares of Healthpeak Properties in the fourth quarter valued at $86,885,000. Finally, JPMorgan Chase & Co. raised its holdings in shares of Healthpeak Properties by 23.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust's stock valued at $493,115,000 after buying an additional 4,056,931 shares during the period. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.